HBV and HCV prevalence in our HD patients is still high. These data emphasize the need for stricter adherence to infection control, barrier precaution and preventive behaviors with all patients.

Hepatitis is disease of the liver caused by the infectious and non-infectious agents. The HBV prevalence among the blood donors of Kosovo is 4.2%, which range Kosovo to the second zone according to the CDC classification of the geographical spread of the HBV infection.The HCV prevalence among the blood donors in Kosovo is 0.3%. Compared to the other European countries this level of prevalence is relatively low.Age group 30-39 years old was presented with 34.8% of cases. The higher number was among the workers, 842 or 26.8%.Based on the results we can conclude that Kosovo have the similar prevalence for HBV and HCV infections as other South East European countries.

Background/Aims: The aim was to determine the sociodemographic and etiologic factors, endoscopic accuracy, treatment efficiency and clinical outcome of patients with nonvariceal upper gastrointestinal system bleeding in Kosova. Materials and Methods: We retrospectively evaluated patients who had applied to our Gastroenterology Department between January 2006 and December 2010. Results: There were 460 eligible cases with mean age 56.85+16.18 years, while male /female ratio was 2.71/1. The greatest occurrence was at age group of 60-69 years (27.1 %). The most common clinical symptom was melena (62.6%). Comorbid diseases were present in 57, 6% of the patients. The percentage of patients using acetylsalicylic acid and /or other non-steroidal anti-inflammatory drugs was 43.7%. Five point two percent were using anticoagulants. Peptic ulcer was the main cause of bleeding (82.2%) and most of them were Forrest III (41.6%). Endoscopic treatment was performed in 90 patients, primary hemostasis was achieved in 96.7% while rebleeding developed in 10% of these patients. The average length of hospital stay was 9.29+5.58 (1-35) days. Rebleeding was reported in 4.1% of all patients while the overall mortality rate was 5.7%. Conclusion: Age over 60 years, previous history of gastrointestinal bleeding, treatment with anticoagulants, low hemoglobin values at presentation(< 7g/dL), hematemesis, Forrest class, localization of lesion of bleeding, comorbidities, tachycardia, transfusion requirement > 2 unit, type of treatment and time of endoscopy were predictors of poor outcome in study present.

After lung cancer colorectal cancer (Cc) is ranked the second, as a cause of cancer-related death. Th e purpose of this study was to analyze the Cc cases in our material with respect to all prognostic values including histological type and grade, vascular invasion, perineural invasion, and tumor border features. Th ere were investigated  cases of resection specimen with colorectal cancer, which were fi xed in buff ered neutral formalin and embedded in paraffi n. Tissue sections ((μm thick) were cut and stained with H&E. Adenocarcinoma was the most frequent histological type found in , of cases, in , of males and , of females; squamous cell carcinoma in ,, in , of males and , of females; mucinous carcinoma in ,, in , of males and , of females; while adenosquamous carcinoma, undiff erentiated carcinoma and carcinoma in situ in , of cases each. Dukes' classifi cation was used in order to defi ne the depth of invasion. Dukes B was found in , of cases, whereas in , of cases Dukes C was found. As far as histological grading is concerned, Cc was mostly with moderate diff erentiation (,) with neither vascular nor perineural invasion. Resection margins were in all cases free of tumor. Our data indicate that the pathologic features of the resection specimen constitute the most powerful predictors of postoperative outcome in Cc. Dukes' stage and degree of diff erentiation provide independent prognostic information in Cc. However, diff erentiation should be assessed by the worst pattern.

The levofloxacin-based regimen can be one effective therapy for the first-line anti-H. pylori treatment. However, a levofloxacin-based triple therapy is not generally recommended as first-line therapy at the moment due to concerns about the rising prevalence of quinolone-resistant strains in the first-line and second-line anti-H. pylori therapies.